Clinical Trial Update: 12 / 48 Week Pivotal PFT vs PBO in COPD I [Phase 3]

View source ↗

Summary

A Phase 3 pivotal trial comparing the investigational drug PFT to placebo in chronic obstructive pulmonary disease has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PFT

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-04-30